Peptides having specific affinity to pituitary adenylate cyclase

Details Peptides having specific affinity to pituitary adenylate cyclase Peptides having specific affinity to pituitary adenylate cyclase

1996-04-25

2000-01-25

Caputa, Anthony C.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

435 721, 436503, 530300, 530324, 530350, A61K 3900, G01N 33567, C07K 200, C07K 500

Patent

active

060175338

ABSTRACT:
This specification relates to the use of peptides having a specific affinity to pituitary adenylate cyclase activating polypeptide (PACAP) receptors, particularly MAX (67 amino acids), NSP (61 amino acids) and M65 (46 amino acids). MAX and NSP act as agonists to PACAP type 1 receptors, and M65 acts as an antagonist to PACAP type 1 receptors.

REFERENCES:
patent: 5637309 (1997-06-01), Tajima et al.

Affiliated with

Also associated with

Rating

Peptides having specific affinity to pituitary adenylate cyclase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides having specific affinity to pituitary adenylate cyclase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides having specific affinity to pituitary adenylate cyclase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2313854